Cargando…
Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
The aim of this study was to evaluate the long-term response to rituximab in patients with chronic and refractory immune thrombocytopenic purpura (ITP). Adults with ITP fail to respond to conventional therapies in almost 30% of cases, developing a refractory disease. Rituximab has been successfully...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040174/ https://www.ncbi.nlm.nih.gov/pubmed/17874322 http://dx.doi.org/10.1007/s00277-007-0317-3 |